RT @ArthurRheum: Baricitinib additional improvement in pain vs ADA despite accounting for effect on disease activity https://t.co/zAjS2dOay…
Tweet Content
Baricitinib additional improvement in pain vs ADA despite accounting for effect on disease activity https://t.co/zAjS2dOayF @RheumNow
Show on Archive Page
On
Display in Search Results
On